Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Robbins

Showing results (981-990 of 1,002) with videos related to

Pageof 101
Sort By:
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Mutation Research|September 1, 2012
Harnessing genomics to identify environmental determinants of heritable diseaseCarole Lyn Yauk, J Lucas Argueso, Scott S Auerbach, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2022
Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood MeasurementsKarl Smith-Byrne, Agustin Cerani, Florence Guida, et al.
Immunohorizons|March 26, 2025
Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial dataJohannes F Scheid, Kiki Cunningham-Bussel, Nancy Kim, et al.
JAMA|May 18, 2026
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk ModelHana Zahed, Xiaoshuang Feng, Karine Alcala, et al.
Scientific Reports|January 18, 2023
A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort ConsortiumØivind Midttun, Arve Ulvik, Klaus Meyer, et al.
Journal of the National Cancer Institute|June 1, 2023
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction toolsXiaoshuang Feng, Wendy Yi-Ying Wu, Justina Ucheojor Onwuka, et al.
Ebiomedicine|December 7, 2025
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2019
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortiumA R Kreimer, A Ferreiro-Iglesias, M Nygard, et al.
Nature Genetics|July 5, 2016
Genome-wide association of multiple complex traits in outbred mice by ultra-low-coverage sequencingJérôme Nicod, Robert W Davies, Na Cai, et al.
Pageof 101

Showing results (981-990 of 1,002) with videos related to

Sort By:
Pageof 101
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Mutation Research|September 1, 2012
Harnessing genomics to identify environmental determinants of heritable diseaseCarole Lyn Yauk, J Lucas Argueso, Scott S Auerbach, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2022
Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood MeasurementsKarl Smith-Byrne, Agustin Cerani, Florence Guida, et al.
Immunohorizons|March 26, 2025
Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial dataJohannes F Scheid, Kiki Cunningham-Bussel, Nancy Kim, et al.
JAMA|May 18, 2026
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk ModelHana Zahed, Xiaoshuang Feng, Karine Alcala, et al.
Scientific Reports|January 18, 2023
A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort ConsortiumØivind Midttun, Arve Ulvik, Klaus Meyer, et al.
Journal of the National Cancer Institute|June 1, 2023
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction toolsXiaoshuang Feng, Wendy Yi-Ying Wu, Justina Ucheojor Onwuka, et al.
Ebiomedicine|December 7, 2025
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2019
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortiumA R Kreimer, A Ferreiro-Iglesias, M Nygard, et al.
Nature Genetics|July 5, 2016
Genome-wide association of multiple complex traits in outbred mice by ultra-low-coverage sequencingJérôme Nicod, Robert W Davies, Na Cai, et al.
Pageof 101